CAS: 1421438-81-4
![Butanamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluoro-](https://static.cymitquimica.com/products/AN/thumb/AG001HUJ.jpg)
Butanamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluoro-
CAS:1421438-81-4
Formula:
C22H23F3N4O4
Purity:
95%
Color and Shape:
Solid
Molecular weight:
464.4376
Ref: AN-AG001HUJ
| 5mg | 151.00 € | |
| 10mg | 254.00 € | |
| 25mg | 476.00 € | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
Crenigacestat
CAS:1421438-81-4
Crenigacestat (LY3039478) is an orally bioavailable Notch inhibitor with an IC50 of ~1 nM in …
Formula:
C22H23F3N4O4
Purity:
98.76%
Color and Shape:
Solid
Molecular weight:
464.44
Ref: TM-T3633
| 1mg | 60.00 € | |
| 5mg | 118.00 € | |
| 10mg | 184.00 € | |
| 25mg | 346.00 € | |
| 50mg | To inquire | |
| 1ml*10 (DMSO) | 119.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
LY3039478
CAS:1421438-81-4
Inhibitor of NOTCH signalling
Formula:
C22H23F3N4O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
464.44 g/mol
Ref: 3D-FT76166
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 3 Jun 2024
Ref: TR-L468970
| 100mg | 17,769.00 € |
Estimated delivery in United States, on Monday 1 Jul 2024
